The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway

Published:2012-04-16 Issue:6 Volume:5 Page:810-821
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Cabrera M. Carla,Díaz-Cruz Edgar S.,Kallakury Bhaskar V.S.,Pishvaian Michael J.,Grubbs Clinton J.,Muccio Donald D.,Furth Priscilla A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991;Evidence-Based Complementary and Alternative Medicine;2022-03-03

2. Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series;Therapeutic Advances in Medical Oncology;2021-01

3. Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition;Molecular Cancer Research;2019-08-05

4. Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer;Expert Opinion on Pharmacotherapy;2013-12-26

5. The PPARγ Agonist Efatutazone Increases the Spectrum of Well-Differentiated Mammary Cancer Subtypes Initiated by Loss of Full-Length BRCA1 in Association with TP53 Haploinsufficiency;The American Journal of Pathology;2013-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP